Modest Individual Gains, Meaningful Population Effect
This Viewpoint discusses the new drug application for giredestrant and how this could impact treatment of patients with breast cancer.
Authors
- Meredith M. Regan (ORCID: https://orcid.org/0000-0002-2428-6109)
- Lajos Pusztai (ORCID: https://orcid.org/0000-0001-9632-6686)
- Sara M. Tolaney (ORCID: https://orcid.org/0000-0002-5940-8671)
- Marco Mariani (ORCID: https://orcid.org/0009-0000-7444-8578)
Institutions
- Yale Cancer Center (US)
- Yale University (US)
- Dana-Farber Cancer Institute (US)
- IRCCS Ospedale San Raffaele (IT)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1001/jamaoncol.2026.4550
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00